🛒 From Snack Aisle to Fitting Room: How GLP-1 Users Are Shopping Now
A new EY-Parthenon survey finds that 54% of U.S. GLP-1 users now take the medication mainly for weight management, and their grocery carts and closets are changing too.
-
-
💊 Europe Nears a Yes on Foundayo, Lilly’s Once-Daily GLP-1 Pill
Europe’s drug committee recommended EU approval of Eli Lilly’s once-daily GLP-1 pill Foundayo, leaving one final sign-off before it can reach European pharmacies.